companydata.dkcompanydata.dk

WEST PHARMACEUTICAL SERVICES DANMARK ApS: Financial statements 2020

CVR: 16210714

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

WEST PHARMACEUTICAL SERVICES DANMARK ApS (CVR 16210714) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 618,391,000 and a net result of DKK 24,629,000 compared with DKK 37,620,000 the year before. That is an increase of 3.9% compared with the year before. The profit margin was 4%. Equity in the 2020 report amounted to DKK 860,012,000. The solvency ratio was 54.4%. The company had 223 employees in the financial year.

Revenue
DKK 618,391,000
Gross Profit
DKK 118,583,000
Profit/Loss
DKK 24,629,000
Equity
DKK 860,012,000
Total Assets
DKK 1,580,646,000
Employees
223

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020618.4 mio.118.6 mio.24.6 mio.860 mio.223
2019595.2 mio.113 mio.37.6 mio.835.4 mio.227
2018579.7 mio.144.5 mio.371.2 mio.404 mio.227
2017521.7 mio.127.5 mio.375.7 mio.2.1 mia.212
2016519.7 mio.142.9 mio.354.4 mio.2.1 mia.192

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is WEST PHARMACEUTICAL SERVICES DANMARK ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

WEST PHARMACEUTICAL SERVICES DANMARK ApS: The 2019 annual report is outSep 22, 2020

WEST PHARMACEUTICAL SERVICES DANMARK ApS has published its annual report for 2019. Revenue came to DKK 595,181,000, and the net result was DKK 37,620,000.

About WEST PHARMACEUTICAL SERVICES DANMARK ApS

WEST PHARMACEUTICAL SERVICES DANMARK ApS is a Danish company of the type Anpartsselskab based in Horsens, founded in 1999. The company is registered under the industry Fremstilling af letmetalemballage. The company was previously named WEST PHARMACEUTICAL SERVICES DANMARK A/S and THE WEST COMPANY, DANMARK A/S. The management consists of Peter Thorup Hovgaard. The board consists of Shay Kearns (chair), Charlotte Monfeldt Horsbøll, John Ditlev Larsen and Peter Thorup Hovgaard. The company is owned by West Pharmaceutical Services of Delaware, Inc.. The company has 364 employees (2026). In 2025, the company reported revenue of DKK 1,336,445,000 and a net result of DKK 66,980,000 compared with DKK 11,749,681,000 the year before. Equity in the 2025 report amounted to DKK 265,128,000.

Source: annual report 2025, Danish Business Authority